EUVIMEDΑνακαλύψτε το EUVIMED
Crossref

MIF inhibition alleviates vitiligo progression by suppressing CD8 + T cell activation and proliferation

Jianru Chen iD, Weinan Guo iD, Pengran Du iD, Tingting Cui, Yuqi Yang, Yinghan Wang, Pan Kang, Zhe Zhang, Qi Wang, Zhubiao Ye, Ling Liu, Zhe Jian and 4 more

The Journal of Pathology · 2023

DOI: 10.1002/path.6073 ↗

At a glance

Journal article in The Journal of Pathology, 2023. Written by Jianru Chen and 15 co-authors. Institution: Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China. Major MEDLINE topics: Vitiligo, Macrophage Migration-Inhibitory Factors. Cited 23 times so far (Crossref); 52 references. Funded by: National Natural Science Foundation of China.

ΠερίληψηSubjectsΒιβλιογραφικά στοιχείαCiteRelated studies

Abstract (original language)

In vitiligo, autoreactive CD8 + T cells have been established as the main culprit considering its pathogenic role in mediating epidermal melanocyte‐specific destruction. Macrophage migration inhibitory factor (MIF) is a pleiotropic molecule that plays a central role in various immune processes including the activation and proliferation of T cells; but whether MIF is intertwined in vitiligo development and progression and its involvement in aberrantly activated CD8 + T cells remains ill‐defined. In this study, we found that MIF was overabundant in vitiligo patients and a mouse model for human vitiligo. Additionally, inhibiting MIF ameliorated the disease progression in vitiligo mice, which manifested as less infiltration of CD8 + T cells and more retention of epidermal melanocytes in the tail skin. More importantly, in vitro experiments indicated that MIF‐inhibition suppressed the activation and proliferation of CD8 + T cells from the lymph nodes of vitiligo mice, and the effect extended to CD8 + T cells in peripheral blood mononuclear cells of vitiligo patients. Finally, CD8 + T cells derived from MIF‐inhibited vitiligo mice also exhibited an impaired capacity for activation and proliferation. Taken together, our results show that MIF might be clinically targetable in vitiligo treatment, and its inhibition might ameliorate vitiligo progression by suppressing autoreactive CD8 + T cell activation and proliferation. © 2023 The Pathological Society of Great Britain and Ireland.

Subjects

MeSH terms (MEDLINE)

VitiligoMacrophage Migration-Inhibitory FactorsHumansMiceAnimalsCD8-Positive T-LymphocytesLeukocytes, MononuclearMelanocytesCell ProliferationIntramolecular Oxidoreductases

Author keywords

CD8+ T cellMIFactivationmelanocyteproliferationvitiligo

Substances

Macrophage Migration-Inhibitory FactorsMIF protein, humanIntramolecular Oxidoreductases

Authors and institutions

  • Department of Dermatology, Xijing Hospital, Fourth Military Medical University, Xi'an, PR China.
  • National Translational Science Center for Molecular Medicine and Department of Cell Biology, Fourth Military Medical University, Xi'an, PR China.

ORCID profiles: Jianru Chen, Weinan Guo, Pengran Du, Shuli Li, Chunying Li

Funding

  • National Natural Science Foundation of China

Cite

APA

Chen, J., Guo, W., Du, P., Cui, T., Yang, Y., Wang, Y., Kang, P., Zhang, Z., Wang, Q., Ye, Z., Liu, L., Jian, Z., Gao, T., Bian, H., Li, S., & Li, C. (2023). MIF inhibition alleviates vitiligo progression by suppressing CD8 + T cell activation and proliferation. The Journal of Pathology. https://doi.org/10.1002/path.6073

Vancouver

Chen J, Guo W, Du P, Cui T, Yang Y, Wang Y, et al. MIF inhibition alleviates vitiligo progression by suppressing CD8 + T cell activation and proliferation. The Journal of Pathology. 2023. doi:10.1002/path.6073

BibTeX
@article{Chen2023,
  author = {Chen, Jianru and Guo, Weinan and Du, Pengran and Cui, Tingting and Yang, Yuqi and Wang, Yinghan and Kang, Pan and Zhang, Zhe and Wang, Qi and Ye, Zhubiao and Liu, Ling and Jian, Zhe and Gao, Tianwen and Bian, Huijie and Li, Shuli and Li, Chunying},
  title = {MIF inhibition alleviates vitiligo progression by suppressing CD8 + T cell activation and proliferation},
  journal = {The Journal of Pathology},
  year = {2023},
  doi = {10.1002/path.6073}
}
Start for free →